Veterans Agency to Offer New Depression Drug, Despite Cost and Safety Concerns
Confronted with a rising rate of veteran suicides, the Department of Veterans Affairs on Friday decided to approve the use of a new and costly depression drug, despite concerns among doctors and other experts about the drug’s effectiveness. The decision to endorse the drug — called Spravato, and manufactured by Janssen, a unit of Johnson…
Details